According to a market report by Lucintel, the future of the nucleic acid drug market in United States looks promising with opportunities in the genetic disease, cancer, and cardiovascular disease markets. The nucleic acid drug market in United States is expected to grow with a CAGR of 13.7% from 2025 to 2031. The major drivers for this market are the growing prevalence of genetic disorders, increasing demand for treating diseases at the genetic level, and rising awareness about the benefits of nucleic acid drugs.
A more than 150-page report to understand trends, opportunity and forecast in nucleic acid drug market in United States to 2031 by type (antisense nucleic acid drugs, SiRNA drugs, SaRNA drugs, MiRNA drugs, MRNA drugs, and others) and application (genetic disease, cancer, cardiovascular diseases, and others).
Download sample by clicking on nucleic acid drug market in United States
Lucintel forecasts that, within the type category, antisense nucleic acid drug is expected to witness the highest growth over the forecast period.
Within the application category, genetic disease is expected to witness the highest growth.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Nucleic Acid Drug Market in Australia
Nucleic Acid Drug Market in Brazil
Nucleic Acid Drug Market in Canada
Nucleic Acid Drug Market in Mexico
Nucleic Acid Drug Market in Saudi Arabia
Nucleic Acid Drug Market in South Africa